Across TCGA pan-cancer cohorts, IGLV8OR8-1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of IGLV8OR8-1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where IGLV8OR8-1 RNA is repressed in tumor relative to normal tissue. In most cancer types IGLV8OR8-1 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD, LUAD, and KIRC are the cancer types where IGLV8OR8-1 tumor–normal differential expression is most reproducible.